Jayanti Mukherjee
About
Jayanti Mukherjee is a scholar working on Endocrinology, Diabetes and Metabolism, Economics and Econometrics and Analytical Chemistry.
According to data from OpenAlex, Jayanti Mukherjee has authored 54 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Economics and Econometrics and 7 papers in Analytical Chemistry. Recurrent topics in Jayanti Mukherjee's work include Diabetes Treatment and Management (18 papers), Diabetes Management and Research (13 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Jayanti Mukherjee is often cited by papers focused on Diabetes Treatment and Management (18 papers), Diabetes Management and Research (13 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Jayanti Mukherjee collaborates with scholars based in United States, Canada and India. Jayanti Mukherjee's co-authors include D. Wayne Taylor, D L Sackett, Charles D. Bernholz, R. Brian Haynes, Sarah E. Holden, Sara Jenkins‐Jones, Craig J. Currie, Biswanath Bhunia, Uchenna H. Iloeje and Christopher Ll. Morgan and has published in prestigious journals such as The Science of The Total Environment, Diabetes Care and Food Chemistry.
In The Last Decade
Jayanti Mukherjee
52 papers receiving 2.2k citations
Hit Papers
Peers
Jayanti Mukherjee
Leonard Feldman United States
Jennifer Hirst United Kingdom
Diana M Sobieraj United States
Richard Lewanczuk Canada
Judith P. Kelly United States
Samuel Seidu United Kingdom
Francesco Lapi Italy
James McCormack Canada
Fei‐Yuan Hsiao Taiwan
Martin Schulz Germany
Citations per year, relative to Jayanti Mukherjee Jayanti Mukherjee (= 1×)
peers
Leonard Feldman
Countries citing papers authored by Jayanti Mukherjee
Since
Specialization
Citations
This map shows the geographic impact of Jayanti Mukherjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jayanti Mukherjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jayanti Mukherjee more than expected).
Fields of papers citing papers by Jayanti Mukherjee
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jayanti Mukherjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jayanti Mukherjee. The network helps show where Jayanti Mukherjee may publish in the future.
Co-authorship network of co-authors of Jayanti Mukherjee
This figure shows the co-authorship network connecting the top 25 collaborators of Jayanti Mukherjee. A scholar is included among the top collaborators of Jayanti Mukherjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jayanti Mukherjee. Jayanti Mukherjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Yao, Qing, Alexandre Mercier, A. Nayak, et al.. (2025). Structural and mechanistic insights into herpesvirus helicase–primase and its therapeutic inhibitors. Nature Microbiology. 10(12). 3191–3201.
2.
Sharma, Ramesh, Pinku Chandra Nath, Jayanti Mukherjee, et al.. (2024). Rapid and sensitive approaches for detecting food fraud: A review on prospects and challenges. Food Chemistry. 454. 139817–139817.
3.
Mukherjee, Jayanti, et al.. (2024). Bioremediation of azo dye: A review on strategies, toxicity assessment, mechanisms, bottlenecks and prospects. The Science of The Total Environment. 954. 176426–176426.
4.
Mukherjee, Jayanti, et al.. (2023). Botox Treatment: A Comprehensive Review. Asian Journal of Medicine and Health. 21(11). 349–358.
5.
Mukherjee, Jayanti, John J. Sheehan, Alexandra Ward, et al.. (2017). Delays in treatment intensification with oral antidiabetic drugs and risk of microvascular and macrovascular events in patients with poor glycaemic control: A n individual patient simulation study. Diabetes Obesity and Metabolism. 19(7). 1006–1013.
6.
Durham, Todd A., Kristen Hassmiller Lich, Anthony J. Viera, et al.. (2017). Utilization of Standard and Target-Specific Oral Anticoagulants Among Adults in the United Kingdom With Incident Atrial Fibrillation. The American Journal of Cardiology. 120(10). 1820–1829.
7.
Briggs, Andrew, Deepak L. Bhatt, Benjamin M. Scirica, et al.. (2017). Health-related quality-of-life implications of cardiovascular events in individuals with type 2 diabetes mellitus: A subanalysis from the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR)-TIMI 53 trial. Diabetes Research and Clinical Practice. 130. 24–33.
8.
Mukherjee, Jayanti, Nancy Smith, Kelly Bell, et al.. (2016). Association Between Weight Change, Clinical Outcomes, and Health Care Costs in Patients with Type 2 Diabetes. Journal of Managed Care & Specialty Pharmacy. 22(5). 449–466.
9.
McAdam‐Marx, Carrie, Jayanti Mukherjee, Brandon K. Bellows, et al.. (2014). Evaluation of the relationship between weight change and glycemic control after initiation of antidiabetic therapy in patients with type 2 diabetes using electronic medical record data. Diabetes Research and Clinical Practice. 103(3). 402–411.
10.
Lane, Susan, et al.. (2012). PDB72 The Impact on Utilities of Weight Loss and Weight Gain Among Canadian Patients With Type 2 Diabetes. Value in Health. 15(4). A183–A183.
11.
Beusterien, Kathleen, Shelagh M. Szabo, Jayanti Mukherjee, et al.. (2009). Societal preference values for advanced melanoma health states in the United Kingdom and Australia. British Journal of Cancer. 101(3). 387–389.
12.
Briggs, Andrew, D Wild, Michael Lees, et al.. (2008). Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitation. Health and Quality of Life Outcomes. 6(1). 105–105.
13.
Yuan, Yong, et al.. (2006). Determinants of discontinuation of initial highly active antiretroviral therapy regimens in a US HIV‐infected patient cohort*. HIV Medicine. 7(3). 156–162.
14.
Levy, Adrian R., Lawrence C. McCandless, P. Richard Harrigan, et al.. (2005). Changes in lipids over twelve months after initiating protease inhibitor therapy among persons treated for HIV/AIDS. Lipids in Health and Disease. 4(1). 4–4.
15.
Grover, Steven A., Louis Coupal, Norbert Gilmore, & Jayanti Mukherjee. (2005). Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on cardiovascular risk and life expectancy**The sponsor provided the principal investigator with the results of study AI 424-008 before the study's subsequent publication but did not participate in the data analysis presented in this report. A draft of the manuscript was submitted to the sponsor before submission with the understanding that the final manuscript remained under the complete control of the principal investigator.. The American Journal of Cardiology. 95(5). 586–591.
16.
Maroun, Jean A., Carl V. Asche, Jayanti Mukherjee, et al.. (2003). A Cost Comparison of Oral Tegafur Plus Uracil/Folinic Acid and Parenteral Fluorouracil for Colorectal Cancer in Canada. PharmacoEconomics. 21(14). 1039–1051.
17.
Einarson, Thomas R., Colleen Metge, Michaël Iskedjian, & Jayanti Mukherjee. (2002). An examination of the effect of cytochrome P450 drug interactions of hydroxymethylglutaryl-coenzyme a reductase inhibitors on health care utilization: A Canadian population-based study. Clinical Therapeutics. 24(12). 2126–2136.
18.
Torrance, George W., Valery Walker, Ronald F. Grossman, et al.. (1999). Economic Evaluation of Ciprofloxacin Compared with Usual Antibacterial Care for the Treatment of Acute Exacerbations of Chronic Bronchitis in Patients Followed for 1 Year. PharmacoEconomics. 16(5). 499–520.
19.
Cook, Richard J., et al.. (1999). Two-state mixed renewal processes for chronic disease. Statistics in Medicine. 18(2). 175–188.
20.
Grossman, Ronald F., et al.. (1998). A 1-Year Community-Based Health Economic Study of Ciprofloxacin vs Usual Antibiotic Treatment in Acute Exacerbations of Chronic Bronchitis. CHEST Journal. 113(1). 131–141.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Leonard Feldman Breakdown of academic impact, for papers by Jennifer Hirst Breakdown of academic impact, for papers by Diana M Sobieraj Breakdown of academic impact, for papers by Richard Lewanczuk Breakdown of academic impact, for papers by Judith P. Kelly Breakdown of academic impact, for papers by Samuel Seidu Breakdown of academic impact, for papers by Francesco Lapi Breakdown of academic impact, for papers by James McCormack Breakdown of academic impact, for papers by Fei‐Yuan Hsiao Breakdown of academic impact, for papers by Martin Schulz